Molecular imaging of prostate cancer: PET radiotracers.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 22826388.
- Also identified by DOI 10.2214/AJR.12.8816 and PMC identifier 3408965.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Recent advances in the fundamental understanding of the complex biology of prostate cancer have provided an increasing number of potential targets for imaging and treatment. The imaging evaluation of prostate cancer needs to be tailored to the various phases of this remarkably heterogeneous disease. In this article, I review the current state of affairs on a range of PET radiotracers for potential use in the imaging evaluation of men with prostate cancer.
Medical subject headings
- Molecular Imaging
- Positron-Emission Tomography
- Prostatic Neoplasms
- Radiopharmaceuticals